L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 6.88 NOK 0.88% Market Closed
Market Cap: 341.3m NOK
Have any thoughts about
Lytix Biopharma AS?
Write Note

Lytix Biopharma AS
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Lytix Biopharma AS
Other Current Liabilities Peer Comparison

Comparables:
HBC
B
BGBIO
AZT
N
NYKD
T
TRMED

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
L
Lytix Biopharma AS
OSE:LYTIX
Other Current Liabilities
kr8.5m
CAGR 3-Years
-3%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Other Current Liabilities
kr8.1m
CAGR 3-Years
-9%
CAGR 5-Years
27%
CAGR 10-Years
8%
B
Bergenbio ASA
OSE:BGBIO
Other Current Liabilities
kr34.6m
CAGR 3-Years
-13%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
Nykode Therapeutics ASA
OSE:NYKD
Other Current Liabilities
$10.3m
CAGR 3-Years
38%
CAGR 5-Years
68%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Other Current Liabilities
kr1.8m
CAGR 3-Years
-72%
CAGR 5-Years
-52%
CAGR 10-Years
-8%

See Also

What is Lytix Biopharma AS's Other Current Liabilities?
Other Current Liabilities
8.5m NOK

Based on the financial report for Dec 31, 2023, Lytix Biopharma AS's Other Current Liabilities amounts to 8.5m NOK.

What is Lytix Biopharma AS's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
13%

Over the last year, the Other Current Liabilities growth was -14%. The average annual Other Current Liabilities growth rates for Lytix Biopharma AS have been -3% over the past three years , 13% over the past five years .

Back to Top